Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 276

1.

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.

Shyu KG, Cheng JJ, Kuan P.

J Am Coll Cardiol. 2002 Oct 16;40(8):1383-8.

PMID:
12392825
[PubMed - indexed for MEDLINE]
Free Article
2.

Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?

Kefer JM, Hanet CE, Boitte S, Wilmotte L, De Kock M.

Acta Cardiol. 2003 Dec;58(6):555-60.

PMID:
14713182
[PubMed - indexed for MEDLINE]
3.

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W.

N Engl J Med. 2000 Jul 20;343(3):180-4.

PMID:
10900277
[PubMed - indexed for MEDLINE]
Free Article
4.

Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.

Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G.

J Assoc Physicians India. 2006 Jun;54:449-52.

PMID:
16909692
[PubMed - indexed for MEDLINE]
5.

Acetylcysteine and contrast agent-associated nephrotoxicity.

Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B.

J Am Coll Cardiol. 2002 Jul 17;40(2):298-303.

PMID:
12106935
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.

Awal A, Ahsan SA, Siddique MA, Banerjee S, Hasan MI, Zaman SM, Arzu J, Subedi B.

Mymensingh Med J. 2011 Apr;20(2):264-9.

PMID:
21522098
[PubMed - indexed for MEDLINE]
7.

Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.

Boccalandro F, Amhad M, Smalling RW, Sdringola S.

Catheter Cardiovasc Interv. 2003 Mar;58(3):336-41.

PMID:
12594698
[PubMed - indexed for MEDLINE]
8.

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.

Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF.

JAMA. 2003 Feb 5;289(5):553-8.

PMID:
12578487
[PubMed - indexed for MEDLINE]
9.

Effectiveness of acetylcysteine in prevention of contrast nephropathy.

Azmus AD, Gottschall C, Manica A, Manica J, Duro K, Frey M, Bulc√£o L, Lima C.

J Invasive Cardiol. 2005 Feb;17(2):80-4.

PMID:
15687530
[PubMed - indexed for MEDLINE]
10.

The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity.

Sandhu C, Belli AM, Oliveira DB.

Cardiovasc Intervent Radiol. 2006 May-Jun;29(3):344-7.

PMID:
16502177
[PubMed - indexed for MEDLINE]
11.

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.

Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V.

Eur Heart J. 2004 Feb;25(3):212-8. Review.

PMID:
14972421
[PubMed - indexed for MEDLINE]
Free Article
12.

N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.

Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.

Am Heart J. 2009 Mar;157(3):576-83. doi: 10.1016/j.ahj.2008.11.010. Epub 2009 Feb 6.

PMID:
19249432
[PubMed - indexed for MEDLINE]
13.

Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.

MacNeill BD, Harding SA, Bazari H, Patton KK, Colon-Hernadez P, DeJoseph D, Jang IK.

Catheter Cardiovasc Interv. 2003 Dec;60(4):458-61.

PMID:
14624421
[PubMed - indexed for MEDLINE]
14.

N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.

Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Focaccio A, Ricciardelli B.

J Am Coll Cardiol. 2004 Aug 18;44(4):762-5.

PMID:
15312855
[PubMed - indexed for MEDLINE]
Free Article
15.

Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.

Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM.

Nephrol Dial Transplant. 2008 Apr;23(4):1241-5. doi: 10.1093/ndt/gfm785. Epub 2008 Jan 3.

PMID:
18174269
[PubMed - indexed for MEDLINE]
Free Article
16.

Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.

Fung JW, Szeto CC, Chan WW, Kum LC, Chan AK, Wong JT, Wu EB, Yip GW, Chan JY, Yu CM, Woo KS, Sanderson JE.

Am J Kidney Dis. 2004 May;43(5):801-8.

PMID:
15112170
[PubMed - indexed for MEDLINE]
17.

[Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].

Vallero A, Cesano G, Pozzato M, Garbo R, Minelli M, Quarello F, Formica M.

G Ital Nefrol. 2002 Sep-Oct;19(5):529-33. Italian.

PMID:
12439841
[PubMed - indexed for MEDLINE]
18.

Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.

Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D.

Nephrol Dial Transplant. 2009 Oct;24(10):3103-7. doi: 10.1093/ndt/gfp306. Epub 2009 Jun 23.

PMID:
19549691
[PubMed - indexed for MEDLINE]
Free Article
19.

N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.

Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F.

Trials. 2009 Jun 29;10:45. doi: 10.1186/1745-6215-10-45.

PMID:
19563648
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk